Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Radiation Oncology (London, England)|February 6, 2025
Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective studyAlizée Renan, Marie Bruand, Maria Jolnerovski, et al.Radiation Oncology (London, England)|December 6, 2022
Impact of fractionated stereotactic radiotherapy on activity of daily living and performance status in progressive/recurrent glioblastoma: a retrospective studyNicolas Demogeot, J Salleron, F Rech, et al.Brachytherapy|March 13, 2024
Brachytherapy for favorable prognostic prostate cancer in men up to 60 years of age: Long term follow-upJuliette Jacques, Nassim Sahki, Émilie Meknaci, et al.Journal of Contemporary Brachytherapy|April 8, 2024
Adjuvant pulse-dose-rate brachytherapy for oral cavity and oropharynx carcinoma: Outcome and toxicity assessment of 66 patientsSophie Renard, Nicolas Demogeot, Marie Bruand, et al.Radiation Oncology (London, England)|February 28, 2025
Pattern of recurrence after fractionated stereotactic reirradiation in adult glioblastomaAgathe Margulies, Nassim Sahki, Fabien Rech, et al.International Journal of Radiation Oncology, Biology, Physics|September 1, 2025
Oncological outcomes and organ preservation after brachytherapy for penile carcinoma: A multicentric retrospective study by the Brachytherapy Group of the French Society for Radiation OncologyKanta Ka, Abel Cordoba, Renaud Schiappa, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 13, 2023
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy groupKanta Ka, Renaud Schiappa, Mario Terlizzi, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 14, 2026
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trialMorgan Michalet, Philippe Ronchin, Thomas Reynaud, et al.European Urology|August 15, 2025
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 TrialNicolas Demogeot, Paul Sargos, Julia Salleron, et al.Radiation Oncology (London, England)|November 22, 2024
Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areasCéline Meyer, Sandrine Huger, Marie Bruand, et al.Pageof 1